Clinical trial

Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels

NCT04931420

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2022-05-19

PhasePHASE2

Study timeline

Study start (actual)2022-05-19Date precision: day

Registry last updated2024-07-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Cancerunresolved

Foregut Carcinoid Tumorunresolved

Gastric Adenocarcinomaunresolved

Gallbladder Adenocarcinomaunresolved

Liver Cancerunresolved

GI Cancerunresolved

GI Carcinomaunresolved

Lung Cancerunresolved

Interventions

Standard of Care ChemotherapyDRUG

Video-Assisted Thoracic Surgery (VATS)PROCEDURE

LobectomyPROCEDURE

Consolidative RadiationRADIATION

Ablation TreatmentRADIATION

Resection or ExcisionPROCEDURE

PeritonectomyPROCEDURE

Transarterial RadioembolizationOTHER

Sponsors & collaborators

University of Chicagolead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04931420 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.